CytomX Therapeutics
CTMX
#9714
Rank
NZ$65.2 M
Marketcap
$0.81
Share price
-16.11%
Change (1 day)
-76.18%
Change (1 year)

EPS for CytomX Therapeutics (CTMX)

EPS in 2023 (TTM): -$1.38

According to CytomX Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.50. In 2022 the company made an earnings per share (EPS) of -$3.06 an increase over its 2021 EPS that were of -$3.25.

EPS history for CytomX Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.38-54.71%
2022-$3.06-6.04%
2021-$3.2530.94%
2020-$2.48-52.56%
2019-$5.2445.05%
2018-$3.6172.65%
2017-$2.09-27.78%
2016-$2.8935.65%
2015-$2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.90 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA